Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Moderna’s RSV vaccine mRESVIA gains EC approval
The approval of mRESVIA is underpinned by the ConquerRSV trial, which involved roughly 37,000 adults aged 60 or above. Credit: Mathurin NAPOLY / matnapo on Unsplash.
The approval of mRESVIA is underpinned by the ConquerRSV trial, which involved roughly 37,000 adults aged 60 or above. Credit: Mathurin NAPOLY / matnapo on Unsplash.